{"hands_on_practices": [{"introduction": "Fertilization is a highly specific process, ensuring that only gametes from the same species can fuse. This exercise explores the molecular \"handshake\" between sperm and egg, mediated by the proteins IZUMO1 and JUNO. By applying fundamental principles of thermodynamics, you will calculate the difference in binding energy between a species-matched and a cross-species interaction, providing a quantitative basis for understanding species-specific reproductive barriers [@problem_id:4889770]. This practice demonstrates how biophysical measurements can illuminate the precise mechanisms that govern life's most fundamental events.", "problem": "In mammalian fertilization, the sperm membrane protein IZUMO1 binds the oocyte receptor JUNO to initiate gamete recognition and membrane apposition. Consider cross-reactivity measurements relevant to interspecies compatibility: human IZUMO1 binding to murine JUNO has a dissociation constant $K_{d}$ of $500\\,\\mathrm{nM}$, whereas human JUNO binding to human IZUMO1 has a dissociation constant $K_{d}$ of $10\\,\\mathrm{nM}$. Using only the thermodynamic relationship between equilibrium constants and standard Gibbs free energy for binding at constant temperature and pressure, derive an expression for the relative binding free energy difference $\\Delta\\Delta G$ defined as the standard binding free energy for the cross-reactive pair minus that for the native human pair, evaluated at $37\\,^{\\circ}\\mathrm{C}$. Convert all dissociation constants into $\\mathrm{M}$, assume ideal solution behavior and the same standard state for both measurements, and treat $R$ as the universal gas constant. Compute the numerical value of $\\Delta\\Delta G$, rounding your answer to three significant figures, and express your result in $\\mathrm{kJ/mol}$. Then, based on the sign and magnitude of $\\Delta\\Delta G$, briefly infer whether the cross-species binding would likely be compatible with efficient fertilization under physiological conditions; do not include this qualitative inference in your final numerical answer.", "solution": "The problem is assessed to be valid. It is scientifically grounded in the principles of chemical thermodynamics applied to molecular biology, is well-posed with sufficient and consistent data, and is stated objectively. All conditions for a valid problem are met.\n\nThe fundamental thermodynamic relationship between the standard Gibbs free energy change of a process at equilibrium, $\\Delta G^\\circ$, and its equilibrium constant, $K_{eq}$, at constant temperature $T$ and pressure is given by:\n$$ \\Delta G^\\circ = -RT \\ln(K_{eq}) $$\nwhere $R$ is the universal gas constant.\n\nFor a reversible binding reaction between a protein $P$ and a ligand $L$ to form a complex $PL$, $P + L \\rightleftharpoons PL$, the equilibrium constant is the association constant, $K_a$:\n$$ K_a = \\frac{[PL]}{[P][L]} $$\nThe dissociation constant, $K_d$, is the reciprocal of the association constant:\n$$ K_d = \\frac{1}{K_a} = \\frac{[P][L]}{[PL]} $$\nSubstituting $K_{eq} = K_a = 1/K_d$ into the Gibbs free energy equation yields:\n$$ \\Delta G^\\circ = -RT \\ln\\left(\\frac{1}{K_d}\\right) = RT \\ln(K_d) $$\nThis equation is dimensionally correct when $K_d$ is made dimensionless by dividing by the standard state concentration, $c^\\circ = 1\\,\\mathrm{M}$. Since the problem assumes the same standard state for both measurements and requires conversion of $K_d$ to units of Molarity ($\\mathrm{M}$), we can write the expression for the standard binding free energy for each system.\n\nLet the cross-reactive pair (human IZUMO1, murine JUNO) be denoted by the subscript 'cross' and the native human pair (human IZUMO1, human JUNO) be denoted by the subscript 'native'.\n\nThe standard binding free energy for the cross-reactive pair is:\n$$ \\Delta G^\\circ_{\\text{cross}} = RT \\ln(K_{d, \\text{cross}}) $$\nThe standard binding free energy for the native human pair is:\n$$ \\Delta G^\\circ_{\\text{native}} = RT \\ln(K_{d, \\text{native}}) $$\nThe problem defines the relative binding free energy difference, $\\Delta\\Delta G$, as:\n$$ \\Delta\\Delta G = \\Delta G^\\circ_{\\text{cross}} - \\Delta G^\\circ_{\\text{native}} $$\nSubstituting the expressions for the individual free energies:\n$$ \\Delta\\Delta G = RT \\ln(K_{d, \\text{cross}}) - RT \\ln(K_{d, \\text{native}}) $$\nUsing the logarithmic identity $\\ln(a) - \\ln(b) = \\ln(a/b)$, we derive the final expression for $\\Delta\\Delta G$:\n$$ \\Delta\\Delta G = RT \\ln\\left(\\frac{K_{d, \\text{cross}}}{K_{d, \\text{native}}}\\right) $$\nThis is the required analytical expression. Now, we compute its numerical value.\n\nThe given values are:\n- $K_{d, \\text{cross}} = 500\\,\\mathrm{nM}$\n- $K_{d, \\text{native}} = 10\\,\\mathrm{nM}$\n- $T = 37\\,^{\\circ}\\mathrm{C}$\n- $R = 8.314\\,\\mathrm{J} \\cdot \\mathrm{mol}^{-1} \\cdot \\mathrm{K}^{-1}$\n\nFirst, we convert the temperature to Kelvin:\n$$ T = 37 + 273.15 = 310.15\\,\\mathrm{K} $$\nThe dissociation constants do not need to be converted to Molar units for the ratio, as the units will cancel:\n$$ \\frac{K_{d, \\text{cross}}}{K_{d, \\text{native}}} = \\frac{500\\,\\mathrm{nM}}{10\\,\\mathrm{nM}} = 50 $$\nNow, we can calculate $\\Delta\\Delta G$:\n$$ \\Delta\\Delta G = (8.314\\,\\mathrm{J} \\cdot \\mathrm{mol}^{-1} \\cdot \\mathrm{K}^{-1}) \\times (310.15\\,\\mathrm{K}) \\times \\ln(50) $$\nThe natural logarithm of $50$ is approximately:\n$$ \\ln(50) \\approx 3.91202 $$\nSubstituting this value:\n$$ \\Delta\\Delta G \\approx (8.314 \\times 310.15 \\times 3.91202)\\,\\mathrm{J/mol} $$\n$$ \\Delta\\Delta G \\approx 10086.7\\,\\mathrm{J/mol} $$\nThe problem requires the answer in units of $\\mathrm{kJ/mol}$:\n$$ \\Delta\\Delta G \\approx 10.0867\\,\\mathrm{kJ/mol} $$\nRounding to three significant figures, we get:\n$$ \\Delta\\Delta G = 10.1\\,\\mathrm{kJ/mol} $$\nBased on the result, we can make a brief inference. The positive sign of $\\Delta\\Delta G$ indicates that the cross-species binding is thermodynamically less favorable (weaker) than the native binding. A difference of $10.1\\,\\mathrm{kJ/mol}$ corresponds to a $50$-fold increase in the dissociation constant, signifying a substantial reduction in binding affinity. Such a significant energetic penalty would likely render the cross-species interaction too weak or transient to efficiently mediate the stable membrane apposition required for gamete fusion, suggesting that it would not be compatible with efficient fertilization under physiological conditions.", "answer": "$$ \\boxed{10.1} $$", "id": "4889770"}, {"introduction": "Upon successful binding, the sperm delivers a crucial activating factor, Phospholipase C zeta (PLC$\\zeta$), which initiates a series of calcium oscillations within the oocyte, awakening it from its dormant state. These oscillations are not simple on-off signals; their frequency and amplitude encode vital information for development. This problem challenges you to build a quantitative model of these calcium dynamics using Hill equations, allowing you to predict how deficiencies in PLC$\\zeta$ impact the activation signal and to calculate the requirements for a potential therapeutic intervention [@problem_id:4889719].", "problem": "A clinically observed deficiency in Phospholipase C zeta (PLC$\\zeta$) content within human sperm can attenuate the calcium oscillations that drive oocyte activation during fertilization. Consider an oocyte whose oscillatory calcium dynamics are driven by inositol 1,4,5-trisphosphate ($\\text{IP}_3$) generated in proportion to sperm PLC$\\zeta$ concentration. Let the PLC$\\zeta$ concentration be $C$, with a normal reference value $C_0$. Assume the following foundational bases for modeling oocyte activation:\n\n- The $\\text{IP}_3$ production rate is proportional to PLC$\\zeta$ concentration, and at steady state the $\\text{IP}_3$ level $I$ is proportional to $C$, so $I = \\alpha C$, with $I_0 = \\alpha C_0$ at the normal concentration $C_0$.\n- The opening probability of $\\text{IP}_3$ receptors on the endoplasmic reticulum is cooperative in $I$ and is well described by a Hill relationship with exponent $n_f = 2$ and half-saturation $K_f = I_0$.\n- The oscillation frequency $f$ scales proportionally to this opening probability under the operating range of interest.\n- The oscillation amplitude $A$ scales as a saturating function of $I$ with a Hill-type dependence of exponent $n_A = 1$ and half-saturation $K_A = \\tfrac{1}{2} I_0$.\n\nLet $f_{\\max}$ and $A_{\\max}$ denote the maximal frequency and amplitude under saturating $\\text{IP}_3$, respectively. The patient’s sperm exhibits a reduced PLC$\\zeta$ content of $0.5 C_0$. Supplementation can be achieved either by delivering PLC$\\zeta$ messenger ribonucleic acid (mRNA) or purified PLC$\\zeta$ protein. Assume that only a fraction $\\eta_m = 0.60$ of the delivered mRNA supplementation and a fraction $\\eta_p = 0.85$ of the delivered protein supplementation result in active PLC$\\zeta$ in the ooplasm, due to delivery efficiency and degradation. If $s_m$ and $s_p$ are the supplementation loads expressed as decimal fractions of $C_0$ for mRNA and protein, respectively, the effective PLC$\\zeta$ concentration after supplementation is $C_{\\text{eff}} = 0.5 C_0 + \\eta_m s_m C_0$ for mRNA and $C_{\\text{eff}} = 0.5 C_0 + \\eta_p s_p C_0$ for protein.\n\nTasks:\n\n1. Using the stated bases, model the expected changes in oscillation frequency $f$ and amplitude $A$ at $C = 0.5 C_0$ in terms of $f_{\\max}$ and $A_{\\max}$, and compare them to their normal baselines at $C = C_0$.\n2. Define “normal activation” as simultaneously meeting or exceeding the frequency and amplitude values attained at $C = C_0$. Determine the minimum supplementation load (choosing the more efficient of mRNA or protein routes) required to restore normal activation, expressed as a single decimal fraction of $C_0$.\n\nRound your final answer to four significant figures and report it as a decimal fraction with no units.", "solution": "The problem is scientifically grounded, well-posed, and contains sufficient information to derive a unique solution. The model uses standard principles of biochemical kinetics (Hill equations) applied to a plausible physiological scenario in reproductive biology. I will therefore proceed with a full solution.\n\nThe solution is divided into two parts, corresponding to the two tasks in the problem statement.\n\n**Part 1: Modeling Oscillation Frequency and Amplitude**\n\nFirst, we must establish the mathematical models for oscillation frequency ($f$) and amplitude ($A$) as functions of the PLC$\\zeta$ concentration ($C$).\n\nThe problem states that the $\\text{IP}_3$ level, $I$, is proportional to the PLC$\\zeta$ concentration, $C$, such that $I = \\alpha C$. The normal reference values are $C_0$ and $I_0$, related by $I_0 = \\alpha C_0$.\n\nThe oscillation frequency, $f$, is proportional to the opening probability of $\\text{IP}_3$ receptors. This probability is given by a Hill relationship with exponent $n_f = 2$ and half-saturation constant $K_f = I_0$. The general Hill equation for a process driven by a ligand $I$ is $\\frac{I^{n}}{K^{n} + I^{n}}$. The frequency is maximal ($f_{\\max}$) at saturating $\\text{IP}_3$ levels. Therefore, the frequency $f$ as a function of $I$ is:\n$$ f(I) = f_{\\max} \\frac{I^{n_f}}{K_f^{n_f} + I^{n_f}} = f_{\\max} \\frac{I^2}{I_0^2 + I^2} $$\nSubstituting $I = \\alpha C$ and $I_0 = \\alpha C_0$:\n$$ f(C) = f_{\\max} \\frac{(\\alpha C)^2}{(\\alpha C_0)^2 + (\\alpha C)^2} = f_{\\max} \\frac{\\alpha^2 C^2}{\\alpha^2 C_0^2 + \\alpha^2 C^2} = f_{\\max} \\frac{C^2}{C_0^2 + C^2} $$\n\nThe oscillation amplitude, $A$, follows a saturating Hill-type dependence on $I$ with exponent $n_A = 1$ and half-saturation constant $K_A = \\frac{1}{2} I_0$. The maximal amplitude is $A_{\\max}$. The amplitude $A$ as a function of $I$ is:\n$$ A(I) = A_{\\max} \\frac{I^{n_A}}{K_A^{n_A} + I^{n_A}} = A_{\\max} \\frac{I}{\\frac{1}{2}I_0 + I} $$\nSubstituting $I = \\alpha C$ and $I_0 = \\alpha C_0$:\n$$ A(C) = A_{\\max} \\frac{\\alpha C}{\\frac{1}{2}(\\alpha C_0) + \\alpha C} = A_{\\max} \\frac{\\alpha C}{\\alpha(\\frac{1}{2} C_0 + C)} = A_{\\max} \\frac{C}{0.5 C_0 + C} $$\n\nNow, we can calculate the frequency and amplitude for the normal baseline and the patient's deficient case.\n\n**Normal Baseline ($C = C_0$):**\nThe normal frequency, $f_{\\text{normal}}$, is:\n$$ f_{\\text{normal}} = f(C_0) = f_{\\max} \\frac{C_0^2}{C_0^2 + C_0^2} = f_{\\max} \\frac{C_0^2}{2 C_0^2} = \\frac{1}{2} f_{\\max} $$\nThe normal amplitude, $A_{\\text{normal}}$, is:\n$$ A_{\\text{normal}} = A(C_0) = A_{\\max} \\frac{C_0}{0.5 C_0 + C_0} = A_{\\max} \\frac{C_0}{1.5 C_0} = \\frac{1}{1.5} A_{\\max} = \\frac{2}{3} A_{\\max} $$\n\n**Patient's Deficient Case ($C = 0.5 C_0$):**\nThe patient's frequency, $f_{\\text{patient}}$, is:\n$$ f_{\\text{patient}} = f(0.5 C_0) = f_{\\max} \\frac{(0.5 C_0)^2}{C_0^2 + (0.5 C_0)^2} = f_{\\max} \\frac{0.25 C_0^2}{C_0^2 + 0.25 C_0^2} = f_{\\max} \\frac{0.25 C_0^2}{1.25 C_0^2} = \\frac{0.25}{1.25} f_{\\max} = \\frac{1}{5} f_{\\max} $$\nThe patient's amplitude, $A_{\\text{patient}}$, is:\n$$ A_{\\text{patient}} = A(0.5 C_0) = A_{\\max} \\frac{0.5 C_0}{0.5 C_0 + 0.5 C_0} = A_{\\max} \\frac{0.5 C_0}{1.0 C_0} = \\frac{1}{2} A_{\\max} $$\n\nCompared to their normal baselines, the patient's frequency is $\\frac{f_{\\text{patient}}}{f_{\\text{normal}}} = \\frac{1/5 f_{\\max}}{1/2 f_{\\max}} = \\frac{2}{5} = 0.4$, or $40\\%$ of normal. The patient's amplitude is $\\frac{A_{\\text{patient}}}{A_{\\text{normal}}} = \\frac{1/2 A_{\\max}}{2/3 A_{\\max}} = \\frac{3}{4} = 0.75$, or $75\\%$ of normal.\n\n**Part 2: Minimum Supplementation Load for Normal Activation**\n\n\"Normal activation\" is defined as simultaneously meeting or exceeding the frequency and amplitude values attained at the normal concentration $C = C_0$. Let the effective PLC$\\zeta$ concentration after supplementation be $C_{\\text{eff}}$. The conditions for normal activation are:\n$$ f(C_{\\text{eff}}) \\geq f_{\\text{normal}} $$\n$$ A(C_{\\text{eff}}) \\geq A_{\\text{normal}} $$\nFrom Part 1, we have $f_{\\text{normal}} = f(C_0)$ and $A_{\\text{normal}} = A(C_0)$. The conditions become:\n$$ f(C_{\\text{eff}}) \\geq f(C_0) $$\n$$ A(C_{\\text{eff}}) \\geq A(C_0) $$\nThe derivatives of $f(C)$ and $A(C)$ with respect to $C$ for $C>0$ are:\n$$ \\frac{df}{dC} = f_{\\max} \\frac{2CC_0^2}{(C_0^2 + C^2)^2} > 0 $$\n$$ \\frac{dA}{dC} = A_{\\max} \\frac{0.5 C_0}{(0.5 C_0 + C)^2} > 0 $$\nSince both $f(C)$ and $A(C)$ are monotonically increasing functions of $C$, both inequalities are satisfied if and only if $C_{\\text{eff}} \\geq C_0$. To find the *minimum* supplementation, we set the effective concentration to the minimum required level:\n$$ C_{\\text{eff}} = C_0 $$\n\nWe now calculate the required supplementation load for each route (mRNA and protein) to achieve this target concentration. The initial concentration is $0.5 C_0$.\n\n**mRNA Supplementation:**\nThe effective concentration is $C_{\\text{eff}} = 0.5 C_0 + \\eta_m s_m C_0$. We set this equal to $C_0$:\n$$ 0.5 C_0 + \\eta_m s_m C_0 = C_0 $$\nDividing by $C_0$ (which is non-zero):\n$$ 0.5 + \\eta_m s_m = 1 $$\n$$ \\eta_m s_m = 0.5 $$\nGiven the efficiency $\\eta_m = 0.60$:\n$$ s_m = \\frac{0.5}{\\eta_m} = \\frac{0.5}{0.60} = \\frac{5}{6} $$\n\n**Protein Supplementation:**\nThe effective concentration is $C_{\\text{eff}} = 0.5 C_0 + \\eta_p s_p C_0$. We set this equal to $C_0$:\n$$ 0.5 C_0 + \\eta_p s_p C_0 = C_0 $$\n$$ 0.5 + \\eta_p s_p = 1 $$\n$$ \\eta_p s_p = 0.5 $$\nGiven the efficiency $\\eta_p = 0.85$:\n$$ s_p = \\frac{0.5}{\\eta_p} = \\frac{0.5}{0.85} = \\frac{50}{85} = \\frac{10}{17} $$\n\nTo determine the more efficient route, we compare the required supplementation loads, $s_m$ and $s_p$. The smaller load corresponds to the more efficient method.\n$$ s_m = \\frac{5}{6} \\approx 0.8333... $$\n$$ s_p = \\frac{10}{17} \\approx 0.588235... $$\nSince $s_p  s_m$, protein supplementation is the more efficient route, requiring a smaller load. The minimum supplementation load required to restore normal activation is $s_p$.\n\nThe final answer is the decimal value of $s_p$ rounded to four significant figures.\n$$ s_p = \\frac{10}{17} \\approx 0.58823529... $$\nRounding to four significant figures gives $0.5882$.", "answer": "$$\\boxed{0.5882}$$", "id": "4889719"}, {"introduction": "The calcium signals triggered during activation set in motion a cascade of events, including the critical step of resuming and completing meiosis. To do this, the oocyte must destroy key proteins that hold it in meiotic arrest, most notably cyclin B. This final practice uses the principles of chemical kinetics to model the rapid degradation of cyclin B following egg activation. By solving a first-order decay equation, you will determine the precise timescale required for the oocyte to dismantle its meiotic brake and proceed with forming the zygote [@problem_id:4889700].", "problem": "Egg activation during fertilization triggers a cytosolic calcium rise that activates the Anaphase-Promoting Complex/Cyclosome (APC/C), leading to rapid degradation of cyclin B, exit from metaphase arrest, and zygote formation. Assume that prior to activation the cyclin B concentration is maintained at a pre-activation level $C_{0}$ by ongoing synthesis with a first-order rate constant $k_{\\text{syn}}$ and baseline turnover, and that immediately after activation, synthesis becomes negligible compared to APC/C-mediated degradation. Under these conditions, let the cyclin B concentration $C(t)$ for $t \\geq 0$ obey first-order mass-action kinetics with a post-activation degradation rate constant $k_{\\text{deg}}$, that is, $ \\frac{dC}{dt} = -k_{\\text{deg}}\\,C $ with initial condition $C(0)=C_{0}$. Given $k_{\\text{syn}}=0.02\\,\\text{min}^{-1}$ and $k_{\\text{deg}}=0.2\\,\\text{min}^{-1}$ post-activation, determine the time $t$ required for cyclin B to reach $0.1\\,C_{0}$ after egg activation. Express the final time in minutes and round your answer to three significant figures.", "solution": "The problem asks for the time required for the concentration of cyclin B, denoted by $C(t)$, to decrease to $10\\%$ of its initial value, $C_0$, following egg activation. The dynamics of the concentration for time $t \\geq 0$ are governed by a first-order degradation process.\n\nThe given differential equation is:\n$$ \\frac{dC}{dt} = -k_{\\text{deg}}\\,C $$\nwith the initial condition $C(0) = C_0$. Here, $k_{\\text{deg}}$ is the post-activation degradation rate constant.\n\nThis is a first-order linear homogeneous ordinary differential equation, which can be solved by separation of variables. We rearrange the equation to group terms involving $C$ and $t$ on opposite sides:\n$$ \\frac{dC}{C} = -k_{\\text{deg}}\\,dt $$\nNext, we integrate both sides. The concentration ranges from its initial value $C_0$ at $t=0$ to a value $C(t)$ at time $t$.\n$$ \\int_{C_0}^{C(t)} \\frac{1}{C'}\\,dC' = \\int_0^t -k_{\\text{deg}}\\,dt' $$\nThe integration yields:\n$$ [\\ln(C')]_{C_0}^{C(t)} = [-k_{\\text{deg}}t']_0^t $$\nwhere we have assumed $C0$, as concentration is a positive physical quantity. Evaluating the definite integrals, we get:\n$$ \\ln(C(t)) - \\ln(C_0) = -k_{\\text{deg}}(t - 0) $$\nUsing the logarithmic property $\\ln(a) - \\ln(b) = \\ln(a/b)$, the left side becomes:\n$$ \\ln\\left(\\frac{C(t)}{C_0}\\right) = -k_{\\text{deg}}t $$\nTo solve for $C(t)$, we exponentiate both sides of the equation:\n$$ \\exp\\left(\\ln\\left(\\frac{C(t)}{C_0}\\right)\\right) = \\exp(-k_{\\text{deg}}t) $$\n$$ \\frac{C(t)}{C_0} = \\exp(-k_{\\text{deg}}t) $$\nThis gives the explicit solution for the concentration as a function of time:\n$$ C(t) = C_0 \\exp(-k_{\\text{deg}}t) $$\nThis equation describes the exponential decay of cyclin B. The information about the synthesis rate constant, $k_{\\text{syn}}$, pertains to the establishment of the steady-state concentration $C_0$ before $t=0$ and is not needed for the calculation of the decay process for $t \\geq 0$.\n\nWe need to find the time $t$ at which the concentration $C(t)$ reaches $0.1$ times the initial concentration $C_0$. So we set $C(t) = 0.1\\,C_0$:\n$$ 0.1\\,C_0 = C_0 \\exp(-k_{\\text{deg}}t) $$\nDividing by $C_0$ (which is non-zero) simplifies the equation to:\n$$ 0.1 = \\exp(-k_{\\text{deg}}t) $$\nTo solve for $t$, we take the natural logarithm of both sides:\n$$ \\ln(0.1) = \\ln(\\exp(-k_{\\text{deg}}t)) $$\n$$ \\ln(0.1) = -k_{\\text{deg}}t $$\nIsolating $t$, we find:\n$$ t = -\\frac{\\ln(0.1)}{k_{\\text{deg}}} $$\nUsing the logarithmic identity $\\ln(0.1) = \\ln(10^{-1}) = -\\ln(10)$, we can write $t$ as:\n$$ t = \\frac{\\ln(10)}{k_{\\text{deg}}} $$\nThe problem provides the numerical value for the degradation rate constant, $k_{\\text{deg}} = 0.2\\,\\text{min}^{-1}$. Substituting this value into our expression for $t$:\n$$ t = \\frac{\\ln(10)}{0.2}\\,\\text{min} $$\nUsing the approximate value $\\ln(10) \\approx 2.302585$, we calculate the time:\n$$ t \\approx \\frac{2.302585}{0.2}\\,\\text{min} \\approx 11.512925\\,\\text{min} $$\nThe problem requests the answer to be rounded to three significant figures.\n$$ t \\approx 11.5\\,\\text{min} $$", "answer": "$$\n\\boxed{11.5}\n$$", "id": "4889700"}]}